title: Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.
abstract: Overview of the Disease ProcessIncidencePrognostic FactorsGeneral Therapy StandardsAccomplishments and Lack of Accomplishments During the YearSomatostatin AnalogsPeptide Receptor-Targeted TherapySelective Internal Radiotherapy (SIRT)CYTOTOXIC THERAPIES: TemozolomideVEGF Pathway InhibitorsmTOR InhibitorsDevelopment of BiomarkersWhat Needs to be Done (Application of the Accomplishments)Controversies and DisagreementsHistologic Classification and Staging of Neuroendocrine TumorsClinical Trial Design and End PointsFuture Directions.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Matthew H
authors.initials: MH
authors.lastname: Kulke
authors.forename: Hans
authors.initials: H
authors.lastname: Scherübl